Guanfacine to control ADHD in children and adolescents

  • Chaplin S
N/ACitations
Citations of this article
12Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Guanfacine (Intuniv) is an alpha 2A agonist indicated for the treatment of attention deficit hyperactivity disorder (ADHD) in children and adolescents for whom stimulants are not appropriate. This article discusses the indications, monitoring requirements and clinical trial results. Copyright © 2016 Wiley Interface Ltd

Cite

CITATION STYLE

APA

Chaplin, S. (2016). Guanfacine to control ADHD in children and adolescents. Prescriber, 27(7), 37–38. https://doi.org/10.1002/psb.1481

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free